Meet the Founders

PharPoint Research > About > Meet the Founders

Founding PharPoint Research

PharPoint Research was founded with a rebellious spirit and a firmly focused mission: to create an alternative to rigid, unimaginative, quality-compromised clinical research organizations.

Born of a collaboration between three longtime colleagues with years of experience in the CRO industry, PharPoint Research offers clients both expertise and industry-best customer service. PharPoint was founded on the shared belief that sound business ethics and profit are not mutually exclusive. Our founders have used this approach to build an organization reflective of their personal work ethic and passion for improving therapies around the world, not just the bottom line.

Today, PharPoint’s founding team is still involved in daily operations and the success of our clients. They actively work with our senior management team to continue pushing strategic innovation, industry-best customer service, and high quality in all we do.

Art Holmes, President and CEO
Mr. Holmes has acquired over 26 years of experience in the pharmaceutical industry, including extensive experience in pharmaceutical consulting and contract services. Prior to PharPoint, he founded Databasics Consulting, Inc., a company specializing in systems implementation and validation for pharmaceutical and biotechnology clients. Mr. Holmes has also held management positions at Quintiles Transnational Corp. and PharmaResearch Inc, subsequently known as Kendle International. In his capacity with these companies, he provided leadership in both technical and operational strategies.

Audra McRae, Chief Operating Officer

Ms. McRae’s 24 years of experience in clinical research include both laboratory research and various aspects of clinical trial oversight. In her extensive CRO industry experience, Ms. McRae has directed large international data management departments, providing integration and process development management for three corporate mergers. Active in industry organizations, Ms. McRae is a member of the Society for Clinical Data Management and served on the Board of Directors for the society from 2003 to 2005.

Jennifer A. Elder, PhD, Chief Scientific Officer

Dr. Elder has performed statistical analyses for clinical trials for 24 years. Dr. Elder served as the lead statistician on pivotal studies for two novel compounds in a new class of antiretroviral medications in indications for the treatment of HIV and viral hepatitis. She participated in the completion of several NDA, MAA, sNDA, and IND applications and provided strategic consulting, clinical program development planning, and statistical analysis oversight for over seventy-five projects. Additionally, her experience includes providing statistical support for several pharmaceutical industry sponsored pregnancy registries and phase I through IV clinical trials. Prior to her CRO experience, Dr. Elder was an Assistant Professor of Biostatistics and a statistical consultant at the University of North Carolina at Wilmington where she maintains an adjunct affiliation. Dr. Elder has participated in the authorship of many presentations and has been an invited speaker at several industry conferences.

What's in a name?

What’s the origin of the PharPoint Research name? The premiere episode of Star Trek: The Next Generation is entitled, “Encounter at Farpoint.” With a slight spelling alteration, the name PharPoint refers to the organization’s willingness to explore, innovate, improve, and drive towards the future – to “boldly go.”

To learn more about our corporate mission and values, click here!